Log in to search using one of your social media accounts:

 

Atenolol Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 11, 2017 Category: Drugs & Pharmacology Source Type: news

Generic Atenolol in Short Supply
(MedPage Today) -- The latest sign of turmoil in the generic drug marketplace. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 10, 2017 Category: Cardiology Source Type: news

atenolol and chlorthalidone, Tenoretic
Title: atenolol and chlorthalidone, TenoreticCategory: MedicationsCreated: 6/6/1999 12:00:00 AMLast Editorial Review: 8/7/2017 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - August 7, 2017 Category: Cardiology Source Type: news

Atenolol Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - July 26, 2017 Category: Drugs & Pharmacology Source Type: news

Tenormin (Atenolol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2017 Category: Drugs & Pharmacology Source Type: news

Tenormin I.V. Injection (Atenolol Inj) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2017 Category: Drugs & Pharmacology Source Type: news

Tenoretic (Atenolol and Chlorthalidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2017 Category: Drugs & Pharmacology Source Type: news

Tenormin (Atenolol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 26, 2015 Category: Drugs & Pharmacology Source Type: news

Molecular Dynamics Simulation and NMR Investigation of the Association of the β-Blockers Atenolol and Propranolol with a Chiral Molecular Micelle.
This study is part of a larger effort to understand the mechanism of chiral recognition in capillary electrophoresis by characterizing the molecular micelle binding of chiral compounds with different geometries and charges. Propranolol and atenolol were chosen because their structures are similar, but their chiral interactions with the molecular micelle are different. Molecular dynamics simulations showed both propranolol enantiomers inserted their aromatic rings into the molecular micelle core and that (S)-propranolol associated more strongly with the molecular micelle than (R)-propranolol. This difference was attributed ...
Source: Chemical Physics - August 13, 2015 Category: Chemistry Authors: Morris KF, Billiot EJ, Billiot FH, Hoffman CB, Gladis AA, Lipkowitz KB, Southerland WM, Fang Y Tags: Chem Phys Source Type: news

Excellent review of lipid rescue therapy
3.5 out of 5 stars Intravenous Lipid Emulsion in the Emergency Department: A Systematic Review of Recent Literature. Cao D et al. J Emerg Med 2014 Dec 19 [Epub ahead of print] Abstract This excellent comprehensive review of lipid rescue therapy (LRT) is vitiated only by the unavoidable fact that available clinical evidence  is so inconclusive. As the authors point out, published literature consists mostly of case reports and small case series. The vast majority of these reported cases have good outcomes and reflect positive effects from ILE, but the evidence is marred by multiple confounding variables (such ...
Source: The Poison Review - February 25, 2015 Category: Toxicology Authors: Leon Tags: Medical intralipid lipid emulsion lipid rescue therapy lipid sink Review Source Type: news

atenolol and chlorthalidone, Tenoretic
Title: atenolol and chlorthalidone, TenoreticCategory: MedicationsCreated: 6/6/1999 12:00:00 AMLast Editorial Review: 12/9/2014 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - December 9, 2014 Category: Cardiology Source Type: news

Beta-Blocker, ARB Similarly Protective of Aorta in Marfan'sBeta-Blocker, ARB Similarly Protective of Aorta in Marfan's
There was no placebo in the trial that saw similar aortic-root dimension changes from treatment with atenolol or losartan. If standard therapy with atenolol helped, perhaps losartan did too? Heartwire (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 26, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news

Losartan No Better Than Atenolol In Marfan's Syndrome
Beta-blockers have been the standard treatment for people with Marfan's syndrome, a rare inherited connective tissue disorder that affects about 1 in 5000 people. The goal of treatment is to prevent or slow down the dilation of the aorta and avoid aortic dissection, the main cause of death. In recent years, studies have raised the hope that losartan, an angiotensin receptor blocker, might be more effective than beta-blockers in slowing aortic enlargement. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 19, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Atenolol vs Losartan in Patients With Marfan SyndromeAtenolol vs Losartan in Patients With Marfan Syndrome
Drs Bowen and Connolly discuss the results of a landmark head-to-head comparison of losartan vs atenolol in patients with Marfan syndrome. Mayo Clinic (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 18, 2014 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Beta-blockers expand treatment options for infantile hemangiomas
VANCOUVER, B.C. – Propranolol may have revolutionized the treatment of infantile hemangiomas over the past decade, but other beta-blockers are making inroads in the treatment of these and other pediatric dermatologic disorders. One such beta-blocker is atenolol, a hydrophilic cardioselective agent...googletag.display('div-gpt-ad-cta'); (Source: Skin and Allergy News)
Source: Skin and Allergy News - November 18, 2014 Category: Dermatology Tags: PED News PED Dermatology SAN Expert Analysis SAN Clinical News SAN News SAN Lasers and Treatment Modalities SAN Pediatric Dermatology Source Type: news

atenolol, Tenormin
Title: atenolol, TenorminCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/30/2014 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 30, 2014 Category: Cardiology Source Type: news

Atenolol Beats Lisinopril for HTN in Dialysis (CME/CE)
ATLANTA (MedPage Today) -- For dialysis patients with hypertension and left ventricular hypertrophy, atenolol may provide better blood pressure control than lisinopril, with fewer cardiovascular risks, researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2013 Category: Cardiology Source Type: news

Drugs Reduce Nocturnal BP in Hypertensive Blacks and WhitesDrugs Reduce Nocturnal BP in Hypertensive Blacks and Whites
Atenolol and hydrochlorothiazide (HCTZ) can reduce night blood pressures in blacks and whites with essential hypertension. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2013 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Proteomic Analysis of Vascular Smooth Muscle Cells with S- and R-Enantiomers of Atenolol by iTRAQ and LC-MS/MS
The term “proteome” was first introduced by referring to the complete determination of proteins expressed in a given cell, tissue, or organism. In HPLC-based proteomics technique, the mixture of the cleaved peptides are bonded, separated sequentially on the multidimensional columns based on charge or hydrophobicity of the ionized analytes, and then eluted into the MS for identification. Among the developed stable isotope-based quantification methods, iTRAQ has recently gained popularity as its simple iTRAQ labeling procedures and up to eight labeled samples examined in a single experiment. (Source: Springer pro...
Source: Springer protocols feed by Protein Science - April 15, 2013 Category: Biochemistry Source Type: news

Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Source: BMJ Area: News Beta blockers have been shown in randomised trials to prolong survival, prevent arrhythmia, improve symptoms of heart failure and left ventricular ejection fraction, and control ventricular rate, especially in patients with chronic heart failure. However, controversy exists as to the optimal selection of a particular agent for management of heart failure, as they differ in their selectivity for adrenergic receptors and their effects on the peripheral circulation.   This systematic review and network meta-analysis was conducted of efficacy of different beta- blockers in heart failure to clar...
Source: NeLM - Cardiovascular Medicine - January 17, 2013 Category: Cardiology Source Type: news